Europe's medical cannabis output rising despite economic pressure in 2027
Medical cannabis production in Europe continues to expand even as economic headwinds persist, with Germany's market showing resilience.
FILE — harvest · My 420 Tours / CC BY-SA 4.0Medical cannabis output across Europe is growing despite economic pressure, according to Business of Cannabis, suggesting that regulatory momentum and rising clinical demand are offsetting broader cost-of-living challenges. Germany's market, in particular, appears to be sustaining expansion: related reporting shows the country has approved nearly 500 cultivation licenses and maintains a 300-ton annual medical cannabis cap, while suppliers like Hellenic Dynamics are scaling operations to meet demand.
The resilience contrasts with operational friction elsewhere in the German market. Recent coverage notes price compression (flower prices down 22% while product SKUs jumped 73%) and structural hurdles—building permits and financing gaps have slowed cannabis-club rollout—yet medical production continues its upward trajectory, indicating a bifurcated market where regulated medical supply chains remain insulated from recreational-segment volatility.
Watch for signs of whether medical cannabis producers can sustain output growth if broader European economic conditions worsen, and whether Germany's cultivation capacity continues to expand toward or beyond the 300-ton regulatory ceiling.
Original report: Business of Cannabis ↗